PC-ProC

The effects of phytotherapeutic combination in men with biochemically recurrent prostate cancer – a pilot study

The aim of this pilot study is to investigate the feasibility of a fully-powered randomised controlled trial of the effect of a supplement containing a combination of phytotherapeutic agents – polyphenols (resveratrol, green tea catechins, curcumin) and glucosinolates (broccoli sprout extract) – on decreasing the rate of rise of PSA and PSA doubling time (DT) in men with biochemically-recurrent prostate cancer following local therapy.

Current status:

Completed

Recent publications:

Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials

For more information contact:

Chief Investigator Marie Pirotta, Department of General Practice, University of Melbourne (m.pirotta@unimelb.edu.au, +61 3 8344 9723)